317 related articles for article (PubMed ID: 27507060)
1. Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors.
Lobos-González L; Silva V; Araya M; Restovic F; Echenique J; Oliveira-Cruz L; Fitzpatrick C; Briones M; Villegas J; Villota C; Vidaurre S; Borgna V; Socias M; Valenzuela S; Lopez C; Socias T; Varas M; Díaz J; Burzio LO; Burzio VA
Oncotarget; 2016 Sep; 7(36):58331-58350. PubMed ID: 27507060
[TBL] [Abstract][Full Text] [Related]
2. In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization.
Varas-Godoy M; Lladser A; Farfan N; Villota C; Villegas J; Tapia JC; Burzio LO; Burzio VA; Valenzuela PDT
Pigment Cell Melanoma Res; 2018 Jan; 31(1):64-72. PubMed ID: 28707763
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model.
Borgna V; Villegas J; Burzio VA; Belmar S; Araya M; Jeldes E; Lobos-González L; Silva V; Villota C; Oliveira-Cruz L; Lopez C; Socias T; Castillo O; Burzio LO
Oncotarget; 2017 Jul; 8(27):43692-43708. PubMed ID: 28620146
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.
Vidaurre S; Fitzpatrick C; Burzio VA; Briones M; Villota C; Villegas J; Echenique J; Oliveira-Cruz L; Araya M; Borgna V; Socías T; Lopez C; Avila R; Burzio LO
J Biol Chem; 2014 Sep; 289(39):27182-27198. PubMed ID: 25100722
[TBL] [Abstract][Full Text] [Related]
5. Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors.
Borgna V; Lobos-González L; Guevara F; Landerer E; Bendek M; Ávila R; Silva V; Villota C; Araya M; Rivas A; López C; Socias T; Castillo J; Alarcón L; Burzio LO; Burzio VA; Villegas J
J Cancer; 2020; 11(7):1780-1791. PubMed ID: 32194789
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol analogue, trans-4,4'-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs.
Saha B; Pai GB; Subramanian M; Gupta P; Tyagi M; Patro BS; Chattopadhyay S
Biomed Pharmacother; 2018 Nov; 107():1104-1114. PubMed ID: 30257322
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
[TBL] [Abstract][Full Text] [Related]
8. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
Liu Y; Zhang Y; Zheng X; Zhang X; Wang H; Li Q; Yuan K; Zhou N; Yu Y; Song N; Fu J; Min W
Oncotarget; 2016 May; 7(22):32329-40. PubMed ID: 27058624
[TBL] [Abstract][Full Text] [Related]
11. Efficient in vivo microRNA targeting of liver metastasis.
Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
13. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.
Contador-Troca M; Alvarez-Barrientos A; Barrasa E; Rico-Leo EM; Catalina-Fernández I; Menacho-Márquez M; Bustelo XR; García-Borrón JC; Gómez-Durán A; Sáenz-Santamaría J; Fernández-Salguero PM
Carcinogenesis; 2013 Dec; 34(12):2683-93. PubMed ID: 23843039
[TBL] [Abstract][Full Text] [Related]
14. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
[TBL] [Abstract][Full Text] [Related]
15. Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation.
Bahrambeigi V; Ahmadi N; Salehi R; Javanmard SH
Immunol Invest; 2015; 44(3):216-36. PubMed ID: 25565576
[TBL] [Abstract][Full Text] [Related]
16. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
[TBL] [Abstract][Full Text] [Related]
17. Erythroid differentiation regulator 1, an interleukin 18-regulated gene, acts as a metastasis suppressor in melanoma.
Jung MK; Park Y; Song SB; Cheon SY; Park S; Houh Y; Ha S; Kim HJ; Park JM; Kim TS; Lee WJ; Cho BJ; Bang SI; Park H; Cho D
J Invest Dermatol; 2011 Oct; 131(10):2096-104. PubMed ID: 21697887
[TBL] [Abstract][Full Text] [Related]
18. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
19. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice.
Sun Y; Lin R; Dai J; Jin D; Wang SQ
Oligonucleotides; 2006; 16(4):365-74. PubMed ID: 17155911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
